Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
DAWN Revenue Growth (YoY Quarterly)•+83.92%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+83.92%
+141.5pp
+81.64%
+143.3pp
+0.00%
+150.9pp
+0.00%
+181.8pp
+0.00%
+153.3pp
+0.00%
+150.0pp
+0.00%
+150.0pp
+10.42%
+3.4pp
+10.42%
+3.8pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +313.92% | -57.56% | +83.92% |
| Gross Profit Growth | +0.00% | +0.00% | +302.71% | -61.69% | +81.64% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -150.91% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -181.83% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -153.26% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -150.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -150.00% | +0.00% |
| Weighted Average Shares Growth | +7.33% | +18.49% | +18.31% | +6.99% | +10.42% |
| Weighted Average Shares Diluted Growth | +7.33% | +18.49% | +18.31% | +6.65% | +10.42% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | -111.44% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +115.29% | +92.03% | +92.67% |
| Inventory Growth | +0.00% | +0.00% | +4233.11% | +158.17% | +90.48% |
| Asset Growth | +54.98% | +63.59% | +29.62% | -14.49% | -12.86% |
| Book Value per Share Growth | +35.17% | +36.34% | +26.99% | -24.14% | -20.53% |
| Debt Growth | +537.75% | +872.00% | +1480.53% | +10.63% | +7.34% |
| R&D Expense Growth | +65.53% | -1.47% | -60.75% | -6.39% | -33.77% |
| SG&A Expenses Growth | +34.75% | +10.91% | -4.03% | -2.85% | +14.84% |
1 / 4